chromium has been researched along with Astrocytoma, Grade IV in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, N; Sun, B; Wu, H; Zhan, S; Zhang, G; Zhang, R; Zhou, L | 1 |
| Hirano, H; Kuratsu, J; Nagayama, T; Niiro, M; Oyoshi, T; Takeshima, H | 1 |
| Belan, V; Béres, A; De Riggo, J; Dobrota, D; Galanda, M; Likavcanová, K; Liptaj, T; Mlynárik, V; Prónayová, N | 1 |
| McCusker, RH; Sackett, RL | 1 |
| Kajiwara, M; Komatsu, F | 1 |
| Kasperek, K; Müller, W; Schicha, H; Schröder, R | 1 |
6 other study(ies) available for chromium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma.
Topics: Aged; Antigens, CD; Brain Neoplasms; CD8-Positive T-Lymphocytes; Chromium; Dendritic Cells; Exosomes; Female; Flow Cytometry; Glioblastoma; Histocompatibility Antigens Class I; HSP72 Heat-Shock Proteins; Humans; Lymphocyte Activation; Male; Microscopy, Immunoelectron; Middle Aged; T-Lymphocytes, Cytotoxic | 2011 |
The environment of increased concentration of docosahexaenoic acid in glioblastoma may suppress the anti-tumor effect of macrophages.
Topics: Apoptosis; Brain Neoplasms; Chromium; Docosahexaenoic Acids; Flow Cytometry; Glioblastoma; Humans; Macrophages; Monocytes; Necrosis; Phagocytosis | 2005 |
In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Topics: Aspartic Acid; Astrocytes; Astrocytoma; Brain; Brain Neoplasms; Choline; Chromium; Creatine; Glioblastoma; Glioma; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Neoplasms; Phosphocreatine; Spectrophotometry | 2005 |
Multivalent cations depress ligand binding to cell-associated insulin-like growth factor binding protein-5 on human glioblastoma cells.
Topics: Affinity Labels; Cadmium; Cations; Chromium; Dose-Response Relationship, Drug; Glioblastoma; Gold; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lanthanum; Tumor Cells, Cultured; Zinc | 1998 |
CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.
Topics: Antigens, CD; CD18 Antigens; CD2 Antigens; CD58 Antigens; Cell Adhesion; Cell Adhesion Molecules; Chromium; Cytotoxicity, Immunologic; Glioblastoma; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
[Neutron activation analysis of the trace elements cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium in surgical specimens of human brain tumors. 1].
Topics: Activation Analysis; Antimony; Astrocytoma; Brain Chemistry; Brain Neoplasms; Cesium; Chromium; Cobalt; Ependymoma; Glioblastoma; Humans; Iron; Medulloblastoma; Meningioma; Neurilemmoma; Oligodendroglioma; Papilloma; Rubidium; Scandium; Selenium; Silver; Trace Elements; Zinc | 1974 |